Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
OrthoPediatrics ( (KIDS) ) just unveiled an update.
On May 23, 2025, OrthoPediatrics Corp. held its Annual Meeting of Stockholders where key decisions were made, including the election of directors to serve until 2028. The stockholders approved the compensation of the company’s executive officers and confirmed Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (KIDS) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on OrthoPediatrics stock, see the KIDS Stock Forecast page.
Spark’s Take on KIDS Stock
According to Spark, TipRanks’ AI Analyst, KIDS is a Neutral.
OrthoPediatrics’ overall score is driven by strong positive sentiment from its earnings call and promising revenue growth. However, challenges in profitability and cash flow, along with a bearish technical outlook, weigh down the score. The company’s strategic focus on innovation and market expansion, coupled with optimistic future guidance, are key strengths.
To see Spark’s full report on KIDS stock, click here.
More about OrthoPediatrics
OrthoPediatrics Corp. operates in the medical device industry, focusing on providing orthopedic solutions specifically designed for children. The company offers a range of products aimed at addressing pediatric orthopedic conditions and is a leader in this niche market.
Average Trading Volume: 163,390
Technical Sentiment Signal: Sell
Current Market Cap: $515.9M
See more insights into KIDS stock on TipRanks’ Stock Analysis page.